← Back to Search

Otago Exercise Program for Dementia (ENABLED Trial)

N/A
Recruiting
Led By Deborah A Jehu, PhD
Research Sponsored by Augusta University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3x/week for 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if the Otago Exercise Program combined with usual care can improve thinking skills in people with mild to moderate dementia living in nursing homes. The exercises aim to boost strength and balance, which may help with daily activities and reduce falls.

Who is the study for?
This trial is for people aged 55 or older living with mild to moderate dementia in a nursing home or assisted living facility. Participants must be able to walk, read, write, and speak English, have good enough vision and hearing, expect to live at least another year, and can follow instructions. They need consent from a legal representative.
What is being tested?
The study tests if the Otago Exercise Program plus usual care improves brain function related to planning and decision-making (executive function) over six months better than just usual care. It also looks into other health benefits like mood and balance.
What are the potential side effects?
Since this trial involves an exercise program designed for elderly individuals with dementia, potential side effects may include muscle soreness, fatigue, increased risk of falls during exercises or joint pain due to physical activity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3x/week for 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3x/week for 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in the Color Word Stroop Test
Secondary study objectives
Change in Functional Comorbidity Index
Change in Health Utilities Index-3
Change in body composition (fat (%))
+49 more
Other study objectives
Adverse Events
Cornell Depression Scale
Exercise adherence, measured by the average number of exercise sessions attended
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Otago Exercise Program Plus Usual CareExperimental Treatment1 Intervention
The Otago Exercise Program will be led by a physical therapist in a group setting (5-7 participants/exercise class). The exercise will be 20 min of walking and 30 min of strength and balance exercises 3x/week for 6 months. The physical therapist will select suitable exercises for each participant, such that the exercise is individualized and progressive. Participants will also receive usual care from health care providers (e.g., specialist and local doctor visits, community nurse visits, paid care provider visits, hospitalizations as required, and any ongoing treatment for any illness and/or their comorbidities).
Group II: Usual Care OnlyActive Control1 Intervention
Usual care will consist of routine care from their health care providers (e.g., specialist and local doctor visits, community nurse visits, paid care provider visits, hospitalizations as required, and any ongoing treatment for any illness and/or their comorbidities).

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Exercise interventions, such as the Otago Exercise Program, aim to improve physical and cognitive function in dementia patients through structured physical activity. These programs enhance cardiovascular health, increase cerebral blood flow, reduce inflammation, and promote neuroplasticity, which are essential for maintaining brain health. By improving these physiological parameters, exercise can help slow cognitive decline, improve mood, and enhance the overall quality of life for dementia patients, making it a valuable component of dementia care.

Find a Location

Who is running the clinical trial?

Augusta UniversityLead Sponsor
215 Previous Clinical Trials
85,648 Total Patients Enrolled
2 Trials studying Dementia
699 Patients Enrolled for Dementia
Deborah A Jehu, PhDPrincipal InvestigatorAugusta University

Media Library

Otago Exercise Program Clinical Trial Eligibility Overview. Trial Name: NCT05488951 — N/A
Dementia Research Study Groups: Otago Exercise Program Plus Usual Care, Usual Care Only
Dementia Clinical Trial 2023: Otago Exercise Program Highlights & Side Effects. Trial Name: NCT05488951 — N/A
Otago Exercise Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05488951 — N/A
~12 spots leftby Dec 2025